Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Moxifloxacin and Gemifloxacin on Blood Glucose in Healthy Volunteers
NCT04692623Phase 1Completed
- Sponsor
- Shaheed Benazir Bhutto University
- Start
- Mar 2021
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of moxifloxacin and gemifloxacin in bacterial infection (2 arms), sponsored by Shaheed Benazir Bhutto University. Primary endpoint: Incidence of Hypoglycemia at 4 weeks. Started Mar 2021; status: completed.
02
Drugs
moxifloxacingemifloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04692623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04692623.